ATE12791T1 - Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel. - Google Patents

Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.

Info

Publication number
ATE12791T1
ATE12791T1 AT82400739T AT82400739T ATE12791T1 AT E12791 T1 ATE12791 T1 AT E12791T1 AT 82400739 T AT82400739 T AT 82400739T AT 82400739 T AT82400739 T AT 82400739T AT E12791 T1 ATE12791 T1 AT E12791T1
Authority
AT
Austria
Prior art keywords
octasaccharides
abreviation
see diagramm
denoted below
sequence
Prior art date
Application number
AT82400739T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Jean Choay
Maurice Petitou
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Application granted granted Critical
Publication of ATE12791T1 publication Critical patent/ATE12791T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/02Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007Heparin lyase (4.2.2.7), i.e. heparinase I

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT82400739T 1981-04-29 1982-04-26 Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel. ATE12791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8108604A FR2504928A1 (fr) 1981-04-29 1981-04-29 Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
EP82400739A EP0064452B1 (de) 1981-04-29 1982-04-26 Kurzkettige Oligosaccharide mit biologischen Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendungen als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE12791T1 true ATE12791T1 (de) 1985-05-15

Family

ID=9257922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82400739T ATE12791T1 (de) 1981-04-29 1982-04-26 Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.

Country Status (9)

Country Link
EP (1) EP0064452B1 (de)
JP (1) JPS57190001A (de)
AT (1) ATE12791T1 (de)
CA (1) CA1180292A (de)
DE (1) DE3263083D1 (de)
DK (1) DK189982A (de)
ES (1) ES8302094A1 (de)
FR (1) FR2504928A1 (de)
IE (1) IE52906B1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0209924A1 (de) * 1985-07-12 1987-01-28 Akzo N.V. Antithrombotikum auf Basis von Glykosaminoglykan, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
EP0861903A1 (de) * 1997-02-22 1998-09-02 Lansing, Manfred Verfahren zum reversiblen Immobilisieren von Oligo- oder Polysacchariden
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP1582531A1 (de) 2004-03-24 2005-10-05 Aventis Pharma S.A. Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten
EP1792621B1 (de) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Oral verabreichbare Heparinderivate
EP2279249A4 (de) 2008-05-30 2014-03-05 Momenta Pharmaceuticals Inc Saccharidstrukturen und verfahren zu ihrer herstellung und verwendung
US20190002596A1 (en) * 2015-12-30 2019-01-03 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Sulfated heparin oligosaccharide and preparation method and application thereof
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CA3144968A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
JP7611465B2 (ja) * 2019-10-10 2025-01-10 ジェイ・アイ・サイエンス有限会社 溶離液性の利用フラクションコレクター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
JPH0231721A (ja) * 1988-07-20 1990-02-01 Matsushita Electric Ind Co Ltd 充電式掃除機

Also Published As

Publication number Publication date
DE3263083D1 (en) 1985-05-23
DK189982A (da) 1982-10-30
EP0064452A1 (de) 1982-11-10
CA1180292A (en) 1985-01-02
FR2504928A1 (fr) 1982-11-05
JPS57190001A (en) 1982-11-22
ES511470A0 (es) 1983-02-01
ES8302094A1 (es) 1983-02-01
EP0064452B1 (de) 1985-04-17
IE52906B1 (en) 1988-04-13
FR2504928B1 (de) 1984-02-24
IE820741L (en) 1982-10-29

Similar Documents

Publication Publication Date Title
DE3263083D1 (en) Oligosaccharides with short chains with biological properties, process for their preparation and their uses as medicines
US5770593A (en) Method of determining a pharmaceutical combination preparations for use in anti-neoplastic therapy
ATE25245T1 (de) Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
AR029190A1 (es) Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ES2174064T3 (es) Derivados de 1,3 - dihidro - 1 - (fenilalquil) - 2h - imidazol - 2 - ona que presentan una actividad frente a pde iv y a citoquinas.
DE69431035T2 (de) 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
ATE6645T1 (de) Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK1115697T3 (da) Umættede hydroximsyrederivater som PARP-inhibitorer
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
ATE7202T1 (de) Nichtadsorbierbare, mukolytische verbindungen, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten.
ATE352310T1 (de) Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
Heitlinger et al. Transport of glucose polymer-derived glucose by rabbit jejunum
ATE106874T1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
TR199700508A2 (xx) Orto-ikame edilmi� benzoilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve ayr�ca bunlar� ihtiva eden ila�lar.
ES472528A1 (es) Procedimiento para la preparacion de derivados de benzosul- fonamida
JPS6226221A (ja) 抗変異原性剤
CA2508238A1 (en) Reovirus for the treatment of neoplasia
CH657050A5 (de) Pharmazeutische zubereitung mit kontrollwirkung auf die phagozytfunktionen.
CN116584657A (zh) 抗衰老组合物及其应用
DE3464601D1 (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles, process for their preparation and medicines with anti-thrombotic effects containing them